Absci Corp., a synthetic biology firm whose platform technology aids in drug discovery, has filed for an initial public offering./n
Read MoreBiotech discovery company Absci files for IPO
2021-06-30T20:01:56-04:00June 30th, 2021|
Related Posts
-
Indian digital payments firm discusses IPO plans
April 18th, 2024 -
There’s been a ‘big drop-off’ in Asia-Pacific IPOs: ION Analytics
April 17th, 2024